A. Hellegouarch

Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury

Árpád Tósaki, A. Hellegouarch · Journal of the American College of Cardiology · 1994 · 61 citations

Inflammation, Opening Agent Aggravates, Molecular Physiology +12

The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021

J. Baranès, A. Hellegouarch, M. Le Hégarat et al. · Pharmacological Research Communications · 1986 · 50 citations

Cardiovascular Disease, Cardiovascular System, Medicine +9

Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells

E. Pirotzky, Raphaëlle Delattre, A. Hellegouarch et al. · Clinical Immunology and Immunopathology · 1990 · 26 citations

Inflammation, Cytokine, Tumor Necrosis Factor +12

The Pharmacological Bases for the Vascular Impact of Ginkgo Biloba Extract

Sylvie Delaflotte, A. Hellegouarch, F Clostre · 1988 · 20 citations

Ginkgo Biloba Extract, Pharmacological Study, Herbal Medicine +11

Does the antiarrhythmic effect of DMPO originate from its oxygen radical trapping property or the structure of the molecule itself?

Árpád Tósaki, Reiner F. Haseloff, A. Hellegouarch et al. · Basic Research in Cardiology · 1992 · 17 citations

Antiarrhythmic Effect, Medicine, Physiology +4